Marcus F. Brackeen

<i>N</i>-(2-Benzoylphenyl)-<scp>l</scp>-tyrosine PPARγ Agonists. 1. Discovery of a Novel Series of Potent Antihyperglycemic and Antihyperlipidemic Agents

Brad R. Henke, Steven G. Blanchard, Marcus F. Brackeen et al. · Journal of Medicinal Chemistry · 1998 · 301 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgesics

Paul L. Feldman, Marcus F. Brackeen, Joanne Bilotta et al. · Journal of Medicinal Chemistry · 1991 · 204 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation

Les Sekut, David P. Yarnall, Stephen A. Stimpson et al. · Clinical & Experimental Immunology · 1995 · 123 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.

Michael K. James, Paul L. Feldman, Sascha Schuster et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 120 citations

Medicine, Medicinal Chemistry, Pharmacology +16

A highly selective protocol for the deprotection of BOC-protected amides and carbamates

Jeffrey A. Stafford, Marcus F. Brackeen, Donald S. Karanewsky et al. · Tetrahedron Letters · 1993 · 89 citations

Pharmacy, Medicinal Chemistry, Synthetic Medicinal Chemistry +6